Drug Type AAV based gene therapy |
Synonyms AAV-TPP1-S1S3, M 092, M092 |
Target |
Action modulators |
Mechanism DPAGT1 modulators(dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 modulators), TPP1 modulators(Tripeptidyl Peptidase 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ceroid Lipofuscinosis, Neuronal, 2 | Preclinical | United States | 01 Nov 2024 |